Literature DB >> 11220515

In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.

M J Reed1, K A Scribner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11220515     DOI： 10.1046/j.1463-1326.1999.00014.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  12 in total

1.  Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity model.

Authors:  Elizabeth Rendina-Ruedy; Brenda J Smith
Journal:  Bonekey Rep       Date:  2016-10-26

Review 2.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

3.  Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin.

Authors:  Shao-Yu Wu; Guang-Fa Wang; Zhong-Qiu Liu; Jin-Jun Rao; Lin Lü; Wei Xu; Shu-Guang Wu; Jia-Jie Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-01-05       Impact factor: 6.150

Review 4.  Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-03-06       Impact factor: 2.441

5.  Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.

Authors:  Shelley L Baumgardt; Mark Paterson; Thorsten M Leucker; Juan Fang; David X Zhang; Zeljko J Bosnjak; David C Warltier; Judy R Kersten; Zhi-Dong Ge
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

6.  Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.

Authors:  Sabine Fredersdorf; Christian Thumann; Wolfram H Zimmermann; Roland Vetter; Tobias Graf; Andreas Luchner; Günter Aj Riegger; Heribert Schunkert; Thomas Eschenhagen; Joachim Weil
Journal:  Cardiovasc Diabetol       Date:  2012-05-23       Impact factor: 9.951

7.  BLT2 expression improves skin integrity and protects from alterations caused by hyperglycemia in type 2 diabetes.

Authors:  Alberto Leguina-Ruzzi; Juan P Valderas
Journal:  Dermatoendocrinol       Date:  2016-12-14

8.  Prostate Tumor Cell-Derived IL1β Induces an Inflammatory Phenotype in Bone Marrow Adipocytes and Reduces Sensitivity to Docetaxel via Lipolysis-Dependent Mechanisms.

Authors:  Mackenzie K Herroon; Jonathan D Diedrich; Erandi Rajagurubandara; Carly Martin; Krishna R Maddipati; Seongho Kim; Elisabeth I Heath; James Granneman; Izabela Podgorski
Journal:  Mol Cancer Res       Date:  2019-09-27       Impact factor: 5.852

Review 9.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29

Review 10.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.